Brendan W. Merrell

CIK: 0002090383

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OPRX

OptimizeRx Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

OPRX
OptimizeRx Corp
Aug 21, 2026
Tax Payment(F)
Direct
1K shares at avg. $7.71$8K
OPRX
OptimizeRx Corp
Aug 20, 2026
Award(A)
Direct
57.6K shares-
OPRX
OptimizeRx Corp
Dec 19, 2025
Tax Payment(F)
Direct
289 shares at avg. $13.51$4K
OPRX
OptimizeRx Corp
Dec 11, 2025
Tax Payment(F)
Direct
712 shares at avg. $14.03$10K
OPRX
OptimizeRx Corp
Oct 3, 2025
Tax Payment(F)
Direct
483 shares at avg. $18.75$9K
OPRX
OptimizeRx Corp
Aug 21, 2025
Award(A)
Direct
10.4K shares-

		Type	Shares	Price		Ownership
Aug 21, 2026	OPRX OptimizeRx Corp	Tax Payment(F)	1,020	$7.71	$7,864	Direct
Aug 20, 2026	OPRX OptimizeRx Corp	Award(A)	57,600	-	$0	Direct
Dec 19, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	289	$13.51	$3,904	Direct
Dec 11, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	712	$14.03	$9,989	Direct
Oct 3, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	483	$18.75	$9,056	Direct
Aug 21, 2025	OPRX OptimizeRx Corp	Award(A)	10,417	-	-	Direct

1-6 of 6 transactions

About Merrell Brendan W.

Merrell Brendan W. (SEC CIK 0002090383) files insider reports with the SEC as CHIEF OPERATING OFFICER of OptimizeRx Corp (OPRX).

Signal8 holds 6 ownership filings by Merrell Brendan W. (1 Form 3, 5 Form 4), filed between Nov 10, 2025 and Aug 24, 2026. Those filings report 6 transactions, from Aug 21, 2025 to Aug 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Merrell Brendan W.'s filings is in WALTHAM, MA.

Recent filings by Merrell Brendan W.

Aug 21, 2026: Tax withholding of OPRX shares (Form 4, code F).
Aug 20, 2026: Grant or award of OPRX shares (Form 4, code A).
Dec 19, 2025: Tax withholding of OPRX shares (Form 4, code F).
Dec 11, 2025: Tax withholding of OPRX shares (Form 4, code F).
Oct 3, 2025: Tax withholding of OPRX shares (Form 4, code F).

Other insiders filing for OptimizeRx Corp (OPRX)

D'Silva Andrew J., Chief Business Officer
Silvestro Stephen L, Chief Executive Officer
Odence-Ford Marion, Chief Legal & Admin Officer
Stelmakh Edward, Chief Finance & Strat Officer
KLEMA CATHY, Director
Lang James Paul, Director

How to read Form 4 transaction codes